MEEDER ASSET MANAGEMENT INC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 144 filers reported holding REVANCE THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.5%.

Quarter-by-quarter ownership
MEEDER ASSET MANAGEMENT INC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$130,000
+217.1%
5,241
+94.2%
0.01%
+166.7%
Q1 2020$41,000
+57.7%
2,699
+66.3%
0.00%
+50.0%
Q4 2019$26,000
+85.7%
1,623
+55.6%
0.00%
+100.0%
Q3 2019$14,000
+16.7%
1,043
+69.9%
0.00%0.0%
Q4 2018$12,000
+140.0%
614
+383.5%
0.00%
Q4 2017$5,000
-54.5%
127
-74.9%
0.00%
-100.0%
Q1 2017$11,000
-31.2%
505
-33.5%
0.00%
-50.0%
Q4 2016$16,0007590.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Essex Woodlands Management, Inc. 3,342,047$94,714,00024.58%
Palo Alto Investors LP 2,673,313$75,762,0003.97%
Evolutionary Tree Capital Management, LLC 89,348$2,532,0001.93%
RICE HALL JAMES & ASSOCIATES, LLC 1,121,152$31,773,0001.12%
ArrowMark Colorado Holdings LLC 2,964,135$84,004,0000.65%
Rhenman & Partners Asset Management AB 220,000$6,235,0000.51%
Fosun International Ltd 233,841$6,627,0000.43%
OSTERWEIS CAPITAL MANAGEMENT INC 174,970$4,959,0000.30%
ESSEX INVESTMENT MANAGEMENT CO LLC 76,671$2,173,0000.27%
Tekla Capital Management LLC 213,808$6,059,0000.21%
View complete list of REVANCE THERAPEUTICS INC shareholders